Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

Condition:   Breast CancerInterventions:   Drug: Panitumumab;   Drug: Nab-paclitaxel;   Drug: Carboplatin;   Drug: 5-Fluorouracil;   Drug: Epirubicin;   Drug: CyclophosphamideSponsors:   M.D. Anderson Cancer Center;   Celgene Corporation;   AmgenRecruiting - verified November 2014

Source: ClinicalTrials.gov - December 17, 2009 Category: Research Source Type: clinical trials